Reduced myocardial creatine kinase flux in human myocardial infarction an in vivo phosphorus magnetic resonance spectroscopy study

Circulation

Volumn 119, Issue 14, 2009, Pages 1918-1924

  Bottomley, Paul A ^a,c   Wu, Katherine C ^b   Gerstenblith, Gary ^b   Schulman, Steven P ^b   Steinberg, Angela ^b   Weiss, Robert G ^b  

^a SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Adenosine triphosphate; Creatine kinase; Magnetic resonance spectroscopy; Metabolism; Myocardial infarction

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE KINASE MB; CREATINE PHOSPHATE; GADODIAMIDE; GADOLINIUM; POTASSIUM; CREATINE KINASE; PHOSPHORUS;

ADULT; AGED; ARTICLE; BODY WEIGHT; CELL LOSS; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENERGY; ENERGY TRANSFER; ENZYME KINETICS; ENZYME METABOLISM; FEMALE; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; NON INVASIVE PROCEDURE; OBSERVATIONAL STUDY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; WORKLOAD; ENERGY METABOLISM; ENZYMOLOGY; KINETICS; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REFERENCE VALUE;

ADENOSINE TRIPHOSPHATE; ADULT; CREATINE KINASE; ENERGY METABOLISM; HUMANS; KINETICS; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL INFARCTION; PHOSPHOCREATINE; PHOSPHORUS; REFERENCE VALUES;

EID: 65549089030     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.823187     Document Type: Article

References (35)

1. Jennings RB, Reimer KA. Lethal myocardial ischemic injury. Am J Pathol. 1981;102:241-255.
2. Wallimann T. Bioenergetics: dissecting the role of creatine kinase. Curr Biol. 1994;4:42-46.
3. Ingwall JS, Kramer MF, Fifer MA, Lorell BH, Shemin R, Grossman W, Allen PD. The creatine kinase system in normal and diseased human myocardium. N Engl J Med. 1985;313:1050-1054.
4. Bottomley PA, Hardy CJ, Roemer PB. Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance. Magn Reson Med. 1990;14:425-434.
5. 31P magnetic resonance spectroscopy. Circulation. 1995;92:15-23.
6. Bottomley PA, Atalar E, Weiss RG. Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy. Magn Reson Med. 1996;35:664-670.
7. Bottomley PA, Weiss RG. Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium. Radiology. 2001;219:411-418.
8. Beer M, Seyfarth T, Sandstede J, Landschutz W, Lipke C, Kostler H, von Kienlin M, Harre K, Hahn D, Neubauer S. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol. 2002;40:1267-1274.
9. Nunnally RL, Hollis DP. Adenosine triphosphate compartmentation in living hearts: a phosphorus nuclear magnetic resonance saturation transfer study. Biochemistry. 1979;18:3642-3646.
10. Degani H, Laughlin M, Campbell S, Shulman RG. Kinetics of creatine kinase in heart: a 31P NMR saturation- and inversion-transfer study. Biochemistry. 1985;24:5510-5516.
11. Neubauer S, Hamman BL, Perry SB, Bittl JA, Ingwall JS. Velocity of the creatine kinase reaction decreases in postischemic myocardium: a 31P NMR magnetization transfer study of the isolated ferret heart. Circ Res. 1988;63:1-15.
12. Neubauer S, Horn M, Naumann A, Tian R, Laser M, Gaudron FJ, Schnackerz K, Ingwall JS, Ertl G. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest. 1995;95:1092-1100.
13. Murakami Y, Zhang J, Eijelshoven MHJ, Chen W, Carlyle WC, Zhang Y, Gong G, Bache RJ. Myocardial creatine kinase kinetics in hearts with postinfarction left ventricular modeling. Am J Physiol. 1999;276: H892-H900.
14. Hu Q, Wang X, Lee J, Mansoor A, Liu J, Zeng L, Swingen C, Zhang G, Feygin J, Ochiai K, Bransford TL, From AHL, Bache RJ, Zhang J. Profound bioenergetic abnormalities in peri-infarct myocardial regions. Am J Physiol. 2006;291:H648-H657.
15. Bottomley PA, Ouwerkerk R, Lee RF, Weiss RG. Four angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo. Magn Reson Med. 2002;47:850-863.
16. Weiss RG, Gerstenblith G, Bottomley PA. ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A. 2005;102:808-813.
17. Smith CS, Bottomley PA, Schulman SP, Gerstenblith G, Weiss RG. Altered creatine kinase adenosine triphosphate kinetics in failing hyper- trophied human myocardium. Circulation. 2006;114:1151-1158.
18. Osman NF, Kerwin WS, McVeigh ER, Prince JL. Cardiac motion tracking using CINE harmonic phase (HARP) magnetic resonance imaging. Magn Reson Med. 1999;42:1048-1060.
19. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, Gerstenblith G, Weiss RG, Marban E, Tomaselli GF, Lima JA, Wu KC. Magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007; 115:2006 -2014.
20. Gabr RE, Weiss RG, Bottomley PA. Correcting reaction rates measured by saturation transfer MRS. J Magn Reson. 2008;191:248-258.
21. Bottomley PA, Weiss RG. Noninvasive MRS detection of localized creatine depletion in non-viable, infarcted myocardium. Lancet. 1998; 351:714-718.
22. MC Fishbein MC, Maclean D, Maroko PR. The histopathologic evolution of myocardial infarction. Chest. 1978;73:843-849.
23. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyop-athy. Am Heart J. 1991;122:795-801.
24. Bottomley PA, Ouwerkerk R. Optimum flip-angles for exciting NMR with uncertain T1 values. Magn Reson Med. 1994;32:137-141.
25. Bottomley PA, Hardy CJ, Weiss RG. Correcting human 31P heart spectra for partial saturation: evidence that saturation factors for PCr/ATP are homogeneous in normal and disease states. J Magn Reson. 1991;95: 341-355.
26. Bottomley PA, Herfkens RJ, Smith LS, Bashore TM. Altered phosphate metabolism in myocardial infarction detected by P-31 MR spectroscopy. Radiology. 1987;165:703-707.
27. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: altered cardiac high-energy phosphate metabolism in heart failure. Circulation. 1992;86:1810-1818.
28. Kalil-Filho R, de Albuquerque CP, Weiss RG, Mocelim A, Bellotti G, Cerri G, Pileggi F. Normal high energy phosphate ratios in "stunned" human myocardium. J Am Coll Cardiol. 1997;30:1228-1232.
29. 31P-MR spectroscopy in humans. J Magn Reson Imaging. 2004;20: 798 -802.
30. Yabe T, Mitsunami K, Okada M, Morikawa S, Inubushi T, Kinoshita M. Detection of myocardial ischemia by 31P magnetic resonance spec- troscopy during handgrip exercise. Circulation. 1994;89:1709-1716.
31. 31P magnetic resonance spectroscopy. Lancet. 1991;338:973-976.
32. 31P MR spectroscopy in hypertrophic cardiomyopathy: comparison with Tl-201 myocardial perfusion imaging. Am Heart J. 1993; 125:1323-1328.
33. Lamb HJ, Beyerbacht HP, van der Laarse A, Stoel BC, Doornbos J, van der Wall EE, de Roos A. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation. 1999;99:2261-2267.
34. Swain JL, Sabina RL, Peyton RB, Jones RN, Wechsler AS, Holmes EW. Derangements in myocardial purine and pyramidine nucleotide metabolism in patients with coronary artery disease and left ventricular hypertrophy. Proc Natl Acad Sci U S A. 1982;79:655-659.
35. Bottomley PA, Hardy CJ. Mapping creatine kinase reaction rates in human brain and heart with 4 Tesla saturation transfer 31P NMR. J Magn Reson. 1992;99:443-448.